How do you approach patients with high-risk APL who develop grade 3 pseudotumor cerebri early in consolidation secondary to ATRA that does not improve with maximal medical therapy?   

Patient received gemtuzumab with initial induction. Do you pursue surgical intervention and continue ATRA or would you abandon ATRA and continue ATO + Gemtuzumab?